SCHEMBL15079769

SCHEMBL15079769

CCOC(=O)c1ccc(OCC(O)c2ccccc2O)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.55
TDP1 Q9NUW8 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
CA12 O43570 3/20 0.48
CA1 P00915 3/20 0.48
CA2 P00918 3/20 0.48
CA7 P43166 3/20 0.48
CA9 Q16790 3/20 0.48
CA14 Q9ULX7 3/20 0.48
ESR1 P03372 1/20 0.48
ESR2 Q92731 1/20 0.48
LMNA P02545 3/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
TP53 P04637 1/20 0.47
HSD17B10 Q99714 1/20 0.47
STS P08842 1/20 0.47
GAA P10253 1/20 0.45
ALDH1A1 P00352 3/20 0.44
SCN1A P35498 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15079909 0.87 MAPT (0.52) MAPTTDP1L3MBTL1CA12CA1
SCHEMBL15079364 0.85 MEN1 (0.47) MAPTTDP1L3MBTL1LMNAMEN1
SCHEMBL15079908 0.82 PKM (0.53) MAPTLMNACYP3A4MAPK1
SCHEMBL15079749 0.81 MAPT (0.44) MAPTLMNAMEN1KMT2AGAA
SCHEMBL15079914 0.78 TSHR (0.46) MAPTL3MBTL1LMNAMEN1KMT2A
SCHEMBL7989426 0.78 MAPT (0.58) MAPTTDP1L3MBTL1CA12CA1
SCHEMBL7321684 0.77 MAPT (0.61) MAPTTDP1L3MBTL1CA12CA1
SCHEMBL76052 0.77 ALDH1A1 (0.66) MAPTTDP1L3MBTL1CA12CA1
SCHEMBL14141725 0.77 CA12 (0.44) MAPTTDP1L3MBTL1CA12CA1
SCHEMBL11701711 0.76 MAPT (0.64) MAPTTDP1L3MBTL1CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150004110-A1 NOVEL ANTI-AGING AND DEPIGMENTING COSMETIC COMPOSITIONS DIVERCHIM (FR) 2015-01-01 US disclosed
US-20150004110-A1 NOVEL ANTI-AGING AND DEPIGMENTING COSMETIC COMPOSITIONS DIVERCHIM (FR) 2015-01-01 US disclosed
WO-2013093320-A1 NOVEL ANTI-AGING AND DEPIGMENTING COSMETIC COMPOSITIONS DIVERCHIM (FR) 2013-06-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150004110-A1 NOVEL ANTI-AGING AND DEPIGMENTING COSMETIC COMPOSITIONS ARG1, TYR, NOS1 MAPT 3297/4885TDP1 130/4885L3MBTL1 719/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.